Percutaneous application of peptidoglycan from Staphylococcus aureus induces eosinophil infiltration in mouse skin

Clinical and Experimental Allergy

Volumn 37, Issue 4, 2007, Pages 615-622

  Matsui, K ^a   Wirotesangthong, M ^b   Nishikawa, A ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Atopic dermatitis; Eosinophil; Peptidoglycan; RANTES; Staphylococcus aureus

Indexed keywords

EOTAXIN; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 3; PEPTIDOGLYCAN; RANTES; RANTES MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHILIA; FEMALE; GENE EXPRESSION; IMMUNOHISTOLOGY; IN VITRO STUDY; KERATINOCYTE; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILS; FEMALE; LANGERHANS CELLS; MICE; MICE, INBRED BALB C; PEPTIDOGLYCAN; RANTES; SKIN; STAPHYLOCOCCUS AUREUS; T-LYMPHOCYTES;

EID: 34047221159     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2007.02673.x     Document Type: Article

References (31)

1. Leung DYM. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995; 96:302-19.
2. Gloor M, Peters G, Stoika D. On the resident aerobic bacterial skin flora in unaffected skin of patients with atopic dermatitis and in normal controls. Dermatologia 1992; 164:258-65.
3. Matsui K, Nishikawa A, Suto H, Tsuboi R, Ogawa H. Comparative study of Staphylococcus aureus isolated from lesional and nonlesional skin of atopic dermatitis. Microbiol Immunol 2000; 44:945-7.
4. Lambert PA, Hancock IC, Baddiley J. Occurrence and function of membrane teichoic acids. Biochim Biophys Acta 1977; 472:1-12.
5. Fischer W. Bacterial phosphoglycolipids and lipoteichoic acids. In: Hannah DJ, ed. Handbook of lipid research. New York: Plenum, 1989; 123-234.
6. Matsui K, Motohashi R, Nishikawa A. Cell wall components of Staphylococcus aureus induce interleukin-5 production in patients with atopic dermatitis. J Interferon Cytokine Res 2000; 20:321-4.
7. Matsui K, Nishikawa A. Lipoteichoic acid from Staphylococcus aureus induces Th2-prone dermatitis in mice sensitized percutaneously with an allergen. Clin Exp Allergy 2002; 32:783-8.
8. Matsui K, Nishikawa A. Percutaneous application of peptidoglycan from Staphylococcus aureus induces an increase in mast cell numbers in the dermis of mice. Clin Exp Allergy 2005; 35:382-7.
9. Tada Y, Asahina A, Nakamura K, Tomura M, Fujiwara H, Tamaki K. Granulocyte/macrophage colony-stimulating factor inhibits IL-12 production of mouse Langerhans cells. J Immunol 2000; 164:5113-9.
10. Taskapan MO, Kumar P. Role of staphylococcal superantigens in atopic dermatitis: from colonization to inflammation. Ann Allergy Asthma Immunol 2000; 84:3-12.
11. Jappe U, Heuck D, Witte W, Gollnick H. Superantigen production by Staphylococcus aureus in atopic dermatiti: no more than a coincidence? J Invest Dermatol 1998; 110:844-6.
12. Zollner TM, Wichelhaus TA, Hartung A et al. Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin Exp Allergy 2000; 30:994-1000.
13. Kiehl P, Falkenberg K, Vogelbruch M, Kapp A. Tissue eosinophila in acute and chronic dermatitis: a morphometric approach using quantitative image analysis of immunostaining. Br J Dermatol 2001; 145:720-9.
14. Resnick MB, Weller PF. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 1993; 8:349-55.
15. Lewinsohn DM, Bargatze RF, Butcher EC. Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes and other leukocytes. J Immunol 1987; 138:4313-9.
16. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992; 176:1489-95.
17. Ponath PD, Qin S, Ringler DJ et al. Cloning of the human eosinophil chemoattractant, eotaxin. J Clin Invest 1996; 97:604-12.
18. Forssmann U, Uguccioni M, Loetscher P et al. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 1997; 185:2171-6.
19. Dahinden CA, Geiser T, Brunner T et al. Monocyte chemotactic protein 3 is most effective basophil- and eosinophil-activating chemokine. J Exp Med 1994; 179:751-6.
20. Yamada H, Izutani R, Chihara J, Yudate T, Matsukura M, Tezuka T. RANTES mRNA expression in skin and colon of patients with atopic dermatitis. Int Arch Allergy Immunol 1996; 111 (Suppl. 1):19-21.
21. Yawalkar N, Uguccioni M, Scharer J et al. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 1999; 113:43-8.
22. Taha RA, Minshall EM, Leung DY et al. Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. J Allergy Clin Immunol 2000; 105:1002-7.
23. Sticherling M, Kupper M, Koltrowitz F et al. Detection of the chemokine RANTES in cytokine-stimulated human dermal fibroblasts. J Invest Dermatol 1995; 105:585-91.
24. Yamada H, Matsukura M, Yudate T, Chihara J, Stingl G, Tezuka T. Enhanced production of RANTES, an eosinophil chemoattractant factor, by cytokine-stimulated epidermal keratinocytes. Int Arch Allergy Immunol 1997; 114 (Suppl. 1):28-32.
25. Giustizieri ML, Mascia F, Frezzolini A et al. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 2001; 107:871-7.
26. Re F, Strominger JL. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 2001; 276:37692-9.
27. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-strand RNA and activation of NF-κB by Toll-like receptor 3. Nature 2001; 413:732-8.
28. Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994; 94:870-6.
29. Leung DYM, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004; 113:651-7.
30. Leyden JJ, Marples RR, Klingman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974; 90: 525-9.
31. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991; 96:523-6.